ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Solar Salt Diet in Elderly Hypertensive Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01102023
Recruitment Status : Completed
First Posted : April 12, 2010
Last Update Posted : April 12, 2010
Sponsor:
Collaborators:
Mokpo National University
the ministry of knowledge economy
Information provided by:
Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Brief Summary:

High sodium intake causes hypertension. Various efforts for reducing salt consumption are proceeding all over the world. Solar salt contains reduced sodium and abundant mineral, such as calcium, potassium, and magnesium, comparing to ordinary salt. Use of solar salt, instead of ordinary salt, may have beneficial effects to blood pressure.

The investigators are going to conduct a preliminary study that can support antihypertensive effect of solar salt intake.


Condition or disease Intervention/treatment Phase
Hypertension Other: ordinary salt based- diet Phase 3

Study Type : Interventional  (Clinical Trial)

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sodium
U.S. FDA Resources

Arm Intervention/treatment
Experimental: solar salt based-diet Other: ordinary salt based- diet



Primary Outcome Measures :
  1. Blood pressure


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • above 50 years elderly hypertensive patients
  • possible oral intake

Exclusion Criteria:

  • dementia, GDS>6
  • terminal cancer patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01102023


Locations
Korea, Republic of
Lohas-clover silver hospital
Seoul, Korea, Republic of
Sponsors and Collaborators
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Mokpo National University
the ministry of knowledge economy

ClinicalTrials.gov Identifier: NCT01102023     History of Changes
Other Study ID Numbers: C2009067(254)
First Posted: April 12, 2010    Key Record Dates
Last Update Posted: April 12, 2010
Last Verified: March 2010